Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion description "[An 89-year-old man with severe hypertension (190/82 mm Hg) and chronic heart failure (New York Heart Association class II) despite treatment with benidipine, doxazosin mesylate (INN, doxazosin), and furosemide was given oral candesartan cilexetil (4 mg/d), an angiotensin II type 1 receptor blocker metabolized via cytochrome p450 (CYP) 2C9.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion evidence source_evidence_literature NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion SIO_000772 14586391 NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion wasDerivedFrom befree-20150227 NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_assertion wasGeneratedBy ECO_0000203 NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP230258.RAHvqC32tJ8Jdit6FydKserBcynx3U0mk1QnEJJ1RopAE130_provenance.